Intranasal agomelatine solid lipid nanoparticles to enhance brain delivery: formulation, optimization and in vivo pharmacokinetics

Ahmed M Fatouh1 Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt

Ahmed H Elshafeey1 Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt;2 School of Pharmacy, University of Waterloo, Waterloo, ON, CanadaCorrespondence[email protected]

Ahmed Abdelbary1 Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt

Pages 1815-1825 | Published online: 19 Jun 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

MillanMJGobertALejeuneFThe novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathwaysJ Pharmacol Exp Ther20033063 954 96412750432
PubMed Web of Science ®Google Scholar
AudinotVMaillietFLahaye-BrasseurCNew selective ligands of human cloned melatonin MT1 and MT2 receptorsNaunyn Schmiedebergs Arch Pharmacol20033676 553 56112764576
PubMed Web of Science ®Google Scholar
YousSAndrieuxJHowellHNovel naphthalenic ligands with high affinity for the melatonin receptorJ Med Chem1992358 1484 14861315395
PubMed Web of Science ®Google Scholar
ZupancicMGuilleminaultCAgomelatineCNS Drugs20062012 981 99217140278
PubMed Web of Science ®Google Scholar
HaqueSMdSSahniJKAliJBabootaSDevelopment and evaluation of brain targeted intranasal alginate nanoparticles for treatment of depressionJ Psychiatr Res2014481 1 1224231512
PubMed Web of Science ®Google Scholar
AlsarraIAHamedAYAlanaziFKEl MaghrabyGMVesicular systems for intranasal drug deliveryDrug Delivery to the Central Nervous SystemNew YorkSpringer2010 175 203
Google Scholar
SoaneRHinchcliffeMDavisSIllumLClearance characteristics of chitosan based formulations in the sheep nasal cavityInt J Pharm20012171 183 19111292554
PubMed Web of Science ®Google Scholar
DhuriaSVHansonLRFreyWHIntranasal delivery to the central nervous system: mechanisms and experimental considerationsJ Pharm Sci2010994 1654 167319877171
PubMed Web of Science ®Google Scholar
KozlovskayaLAbou-KaoudMStepenskyDQuantitative analysis of drug delivery to the brain via nasal routeJ Control Release2014189 133 14024997277
PubMed Web of Science ®Google Scholar
JohnsonPHQuaySCAdvances in nasal drug delivery through tight junction technologyExpert Opin Drug Deliv200522 281 29816296754
PubMedGoogle Scholar
BattagliaLGallarateMLipid nanoparticles: state of the art, new preparation methods and challenges in drug deliveryExpert Opinion Drug Deliv201295 497 508
PubMed Web of Science ®Google Scholar
GastaldiLBattagliaLPeiraESolid lipid nanoparticles as vehicles of drugs to the brain: current state of the artEur J Pharm Biopharm2014873 433 44424833004
PubMed Web of Science ®Google Scholar
Lasa-SaracibarBEstella-Hermoso de MendozaAGuadaMDios-VieitezCBlanco-PrietoMJLipid nanoparticles for cancer therapy: state of the art and future prospectsExpert Opin Drug Deliv2012910 1245 126122950878
PubMed Web of Science ®Google Scholar
KaurIPBhandariRBhandariSKakkarVPotential of solid lipid nanoparticles in brain targetingJ Controlled Release20081272 97 109
PubMed Web of Science ®Google Scholar
Garcıa-FuentesMTorresDAlonsoMDesign of lipid nanoparticles for the oral delivery of hydrophilic macromoleculesColloids Surf B2003272 159 168
Web of Science ®Google Scholar
MontgomeryDCDesign and Analysis of Experiments7New YorkWiley1984
Google Scholar
PramanickSExcipient selection in injectable/parenteral formulation developmentPharma Times2013453 65 77
Google Scholar
CDER UGuidance for industry: estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and ResearchRockville, MD2005
Google Scholar
MullerRHMaderKGohlaSSolid lipid nanoparticles (SLN) for controlled drug delivery–a review of the state of the artEur J Pharm Biopharm2000501 161 17710840199
PubMed Web of Science ®Google Scholar
MüllerRHPetersKNanosuspensions for the formulation of poorly soluble drugs: I. Preparation by a size-reduction techniqueInt J Pharm19981602 229 237
Web of Science ®Google Scholar
PhippsLThe High Pressure dairy homogenizer6Reading: National Institute for Research in Dairying1985
Google Scholar
MehnertWMäderKSolid lipid nanoparticles: production, characterization and applicationsAdv Drug Deliv Rev2001472 165 19611311991
PubMed Web of Science ®Google Scholar
RomeoVDdeMeirelesJCGriesWJOptimization of systemic nasal drug delivery with pharmaceutical excipientsAdv Drug Deliv Rev1998291–2 117 13310837583
PubMed Web of Science ®Google Scholar
MoghimiSMPorterCJMuirISIllumLDavisSSNon-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coatingBiochem Biophys Res Commun19911772 861 8662049107
PubMed Web of Science ®Google Scholar
EspositoEFantinMMartiMSolid lipid nanoparticles as delivery systems for bromocriptinePharm Res2008257 1521 153018172580
PubMed Web of Science ®Google Scholar
TsaiMJWuCHuangYBBaicalein loaded in tocol nano-structured lipid carriers (tocol NLCs) for enhanced stability and brain targetingInt J Pharm20124232 461 47022193056
PubMed Web of Science ®Google Scholar
AlamMIBegSSamadAStrategy for effective brain drug deliveryEur J Pharm Sci2010405 385 40320497904
PubMed Web of Science ®Google Scholar
KreuterJApplication of nanoparticles for the delivery of drugs to the brainInt Congress Ser20051277 85 94
Google Scholar
DehouckBFenartLDehouckMPPierceATorpierGCecchelliRA new function for the LDL receptor: transcytosis of LDL across the blood–brain barrierJ Cell Biol19971384 877 8899265653
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Intranasal agomelatine solid lipid nanoparticles to enhance brain delivery: formulation, optimization and in vivo pharmacokinetics

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Intranasal agomelatine solid lipid nanoparticles to enhance brain delivery: formulation, optimization and in vivo pharmacokinetics

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date